TherapeuticsMD Inc (TXMD) — Capital Reinvestment Ratio
Latest as of March 2024:
712.82x
TherapeuticsMD Inc (TXMD) has a Capital Reinvestment Ratio of 712.82x as of March 2024, meaning it reinvests 713% of its operating cash flow ($11.00K) in capital expenditures ($7.84 Million). See free cash flow generation of TherapeuticsMD Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
712.82x
Capex / Operating Cash Flow
Operating Cash Flow
$11.00K
USD
Capital Expenditures
$7.84 Million
USD
Data as of
Mar 2024
Most recent filing
TherapeuticsMD Inc Capital Reinvestment Ratio (1993–2006)
This chart tracks TherapeuticsMD Inc's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for TherapeuticsMD Inc (1993–2006)
Year-by-year Capital Reinvestment Ratio for TherapeuticsMD Inc from 1993 to 2006. For live market cap and broader valuation context, see TherapeuticsMD Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2006 | 0.18x | $329.84K | $57.75K | ▼ -21.7% |
| 2005 | 0.22x | $412.34K | $92.23K | ▼ -85.1% |
| 2004 | 1.50x | $207.73K | $311.05K | ▼ -15.4% |
| 2003 | 1.77x | $140.00K | $247.71K | ▲ +182.6% |
| 2002 | 0.63x | $100.08K | $62.66K | ▲ +367.2% |
| 2001 | 0.13x | $161.95K | $21.70K | ▼ -97.2% |
| 1998 | 4.74x | $44.60K | $211.37K | ▲ +285.1% |
| 1997 | 1.23x | $77.53K | $95.40K | ▲ +639.6% |
| 1995 | 0.17x | $63.45K | $10.56K | ▼ -82.8% |
| 1994 | 0.97x | $72.86K | $70.35K | ▼ -35.9% |
| 1993 | 1.51x | $59.76K | $90.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow